Fraker, D L <br/><br/>
Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Feb 1996 
 - 479-89 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1996.14.2.479  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Alkylating--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Chemotherapy, Cancer, Regional Perfusion<br/>Extremities<br/>Female<br/>Humans<br/>Interferon-gamma--administration & dosage<br/>Male<br/>Melanoma--therapy<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Recombinant Proteins--administration & dosage<br/>Soft Tissue Neoplasms--therapy<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--administration & dosage